— Know what they know.
Not Investment Advice

MDXL OTC

Medixall Group, Inc.
1W: +0.0% 1M: -5.7% 3M: -41.1% YTD: +3200.0% 1Y: +3200.0% 3Y: -98.1% 5Y: -99.7%
$0.00
+0.00 (+0.00%)
 
OTC · Healthcare · Medical - Healthcare Information Services · Tech Score Neutral · Power 50 · $678170 mcap · 188M float · 0.0001% daily turnover

Balance Sheet Trends

Total Assets
$201K -76.7% ▼
5Y CAGR: -22.7%
Total Liabilities
$7M +48.4% ▲
5Y CAGR: +105.0%
Shareholders Equity
-$7M -77.8% ▼
Cash & Investments
$11K +213.8% ▲
5Y CAGR: -44.4%
Total Debt
$4M +35.8% ▲
Net Debt
$4M +35.6% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2019FY2020FY2021FY2022FY2023
— Assets —
Cash$446K$646K$63K$3K$11K
Short-Term Investments$0$0$0$0$0
Cash & ST Investments$446K$646K$63K$3K$11K
Net Receivables$0$0$0$0$0
Inventory$0$0$0$0$0
Other Current Assets$0$8K$3K$8K$3K
Total Current Assets$446K$1M$343K$11K$14K
Property, Plant & Equip.$135K$70K$337K$282K$13K
Goodwill & Intangibles$357K$439K$451K$569K$173K
Long-Term Investments$0$0$0$0$0
Other Non-Current Assets-$492K-$510K-$789K$0$0
Total Non-Current Assets$492K$510K$789K$851K$187K
Total Assets$938K$2M$1M$862K$201K
— Liabilities —
Accounts Payable$161K$571K$589K$1M$3M
Short-Term Debt$71K$25K$69K$3M$4M
Deferred Revenue-$423K-$571K-$589K$0$0
Other Current Liabilities$190K$477K$498K$548K$0
Total Current Liabilities$494K$1M$1M$4M$7M
Long-Term Debt$0$140K$0$0$0
Other Non-Current Liab.$0$0$0$0$0
Total Non-Current Liabilities$46K$140K$246K$189K$0
Total Liabilities$540K$1M$1M$5M$7M
— Equity —
Common Stock$81K$99K$111K$122K$130K
Retained Earnings-$14M-$20M-$26M-$33M-$37M
Accumulated OCI$0$0$0$0$0
Total Stockholders Equity$398K$382K-$340K-$4M-$7M
Total Liabilities & Equity$938K$2M$1M$862K$201K
— Key Metrics —
Total Debt$118K$213K$316K$3M$4M
Net Debt-$329K-$433K$252K$3M$4M
Total Investments$0$0$0$0$0

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms